Cefdinir Capsule
Product Images NDC 72789-061

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 72789-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789061 Label (72789061)

72789061 Label (72789061)
CEFDINIR Capsules, USP are a medication that comes in 20 capsule packaging. It is important to keep the medication out of reach of children and to only use it as directed by a doctor. The medication should be stored tightly and in a light-resistant container as defined by the USP-NF. Each capsule contains 300mg of Cefdinir USP. It is recommended to speak with a doctor regarding potential side effects and to report any side effects experienced while taking the medication. The medication should be finished entirely. The medication is manufactured by Rising Health LLC in Saddle Brook, NJ, and packaged by PD-RX Pharmaceuticals in Oklahoma City, OK. For more information about potential side effects, contact the FDA at 1-800-FDA-1088.*
FDA Label Image

Chemical Structure (Cefdinir Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.